NSIV member, Cellanyx Diagnostics, was awarded the best prostate cancer biomarker poster presentation at the recent 2016 American Urological Association annual meeting. “Cellanyx is currently developing phenotypic tests to address an important unmet clinical need in prostate cancer risk stratification by providing quantitative assessment of tumor aggressiveness and metastatic potential that complements the standard-of-care GleasonRead more
Blog
SolidEnergy began in 2012 at North Shore InnoVentures, a nonprofit technology incubator at Cummings Center in Beverly. In 2013, in collaboration with A123 Venture Technologies, it opened a 3,000-square-foot R&D lab in Waltham. SolidEnergy Systems is moving from Waltham to Woburn and expanding its footprint from 3,000 to 23,000 square feet. The MIT spinoff willRead more
North Shore InnoVentures grad, Arctic Sand, voted one of EE Times “Silicon 60 – Hot Startups to Watch” announced in February, 2016, completion of a $19M Series B Financing round. The company, headquartered in Burlington MA, has the industry-leading ARC1C0608 LED boost converter – the most efficient thinnest and smallest LED driver IC on theRead more
NSIV member, CrowdComfort, was featured in the WSJ last week in an article about high tech approaches being used to resolve the constant battle around the office thermostat. In addition to reporting uncomfortable conditions, CrowdComfort’s app leverages crowd-sourced occupant feedback to improve safety and operations in workplaces, unlock efficiencies in facilities management and preventative maintenance, increase employeeRead more
New England Hydropower Company (NEHC), a member of North Shore InnoVentures, has added two summer interns. Joining NEHC from Worcester Polytechnic Institute (WPI) and University of Massachusetts Lowell, the students will be working here and at a construction project in CT – NEHC’s first Archimedes Screw Turbine installation in the US.Read more
Genomic Expression, first mover in making RNAsequencing actionable in oncology, announced that it has won the Red Herring Top 100 North America award and has also been recognized by Sir Richard Branson. The award recognizes leading private companies, celebrating these startups’ innovations and technologies across their respective industries.Read more
NSIV member, Cellanyx Diagnostics, was awarded the best prostate cancer biomarker poster presentation at the recent 2016 American Urological Association annual meeting. “Cellanyx is currently developing phenotypic tests to address an important unmet clinical need in prostate cancer risk stratification by providing quantitative assessment of tumor aggressiveness and metastatic potential that complements the standard-of-care GleasonRead more